The Scripps Research Institute - At The Forefront
January 2015 Connect with us:
facebook
twitter
youtube
Focus on:
Help Cure Ebola in Your Sleep

You can help us find a cure for Ebola simply by lending us the use of your computer. No financial contribution, passport, or PhD is necessary. In fact, all you have to do is download free software that will take advantage of the unused processing capacity on your device (even while you are asleep, traveling, or on a coffee break) to provide the computing capability our scientists need to find answers about Ebola.

Read More

The Scripps Research Institute's Professor Erica Ollmann Saphire is leading the new effort against Ebola.
TSRI's collaborative approach to research is breaking new ground in treating conditions and diseases ranging from memory loss to Ebola. Please support our life-saving work today. donate now
 
Scripps Research Institute Professor Hugh Rosen (above) collaborated with his colleague Professor Ed Roberts on the initial development of RPC-1063.
milestones in medical science:
MS Drug Candidate Could Also Help Treat Ulcerative Colitis

Ulcerative colitis is a form of inflammatory bowel disease characterized by chronic inflammation in the colon and rectum, and its global incidence and prevalence seem to be increasing with time. While existing medications do help some patients, 23 to 45 percent of ulcerative colitis sufferers eventually require surgical removal of all, or part of, the colon.

Now, a drug candidate discovered at Scripps Florida and developed by Scripps California Professors Hugh Rosen and Ed Roberts has shown potential to significantly improve the treatment paradigm for ulcerative colitis patients.

Read More

TSRI Assistant Professor Sathyanarayanan V. Puthanveettil
Other News:
New Tests to Screen for Memory Disorders

Scientists from Scripps Florida have identified a number of new therapeutic targets for memory disorders and developed a new screening test to uncover compounds that may one day work against those disorders. Two studies, both led by TSRI biologist Sathyanarayanan V. Puthanveettil, could lead to new approaches to treating some of the most problematic diseases facing a rapidly aging global population, including Alzheimer's disease, Huntington's disease, and dementia.

Read More

TSRI Research Voted People's Choice for 2014

Research from the lab of Floyd Romesberg, professor at TSRI, has been voted the People's Choice for the Breakthrough of the Year in an online competition sponsored by the journal Science.

Dr. Romesberg and his colleagues engineered a bacterium whose genetic material includes an added pair of DNA “letters” not found in nature. Their work could lead to many exciting applications, from new medicines to nanotechnologies. Read more here.
facts & figures

The average death rate during past Ebola outbreaks has ranged from 25% to 90%.
The Scripps Research Institute
donate now
California: 10550 North Torrey Pines Road TPC2, La Jolla, CA 92037 - (800) 788-4931
Florida: 130 Scripps Way, Jupiter, FL 33458 - (561) 228-2013

philanthropy@scripps.edu   •   www.supportcures.org